C60.2
BillableMalignant neoplasm of body of penis
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is C60.2 an HCC code?
Yes. C60.2 maps to Melanoma and Other Skin Cancers under the CMS-HCC V28 risk adjustment model (and Breast, Prostate, and Other Cancers and Tumors under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for C60.2
For C60.2 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C60.2 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
C60.2 is the ICD-10-CM diagnosis code for malignant neoplasm of body of penis. Cancer that occurs in the shaft or body of the penis. This malignant tumor affects the main cylindrical portion of the penis. C60.2 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of male genital organs (c60-c63).
Under the CMS-HCC V28 risk adjustment model, C60.2 maps to Melanoma and Other Skin Cancers (HCC 23) with a community, non-dual, aged base RAF weight of 0.251. Under the older CMS-HCC V24 model, C60.2 maps to Breast, Prostate, and Other Cancers and Tumors (HCC 12) with a community, non-dual, aged base RAF weight of 0.150. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Distinguish between the body of the penis and other penile sites like the glans or prepuce. Because C60.2 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C60.2 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Distinguish between the body of the penis and other penile sites like the glans or prepuce
- •Document whether the tumor involves the corpora cavernosa or corpus spongiosum if available
Clinical Significance
Malignant neoplasm of the body (shaft) of the penis is a subsite-specific penile cancer code. Shaft cancers may involve the corpora cavernosa or corpus spongiosum and tend to present at a more advanced stage than glans tumors because they are less visible. Accurate subsite coding is important for surgical planning and prognosis determination.
Documentation Requirements
- ✓Pathology confirming malignancy of the penile shaft/body
- ✓Histologic type and grade
- ✓Depth of invasion — whether corpora cavernosa or corpus spongiosum is involved
- ✓TNM staging
- ✓Lymph node status (inguinal and pelvic)
- ✓Treatment plan